Skip to Content

Facing the Future Without PFAS: Is Your Business Prepared?

Download our whitepaper to learn:

  • An overview of the PFAS ban and its implications
  • How PFAS are used in medical devices and pharmaceuticals
  • The evolving global regulatory landscape
  • Potential impacts on the healthcare sector
  • Strategic approaches for transitioning away from PFAS
Submit for White Paper

Thank you for submitting From!

You can Download our white paper from here

Download


​

The healthcare industry, being highly regulated, frequently encounters challenges resulting from shifts in global regulatory frameworks. A major regulatory challenge currently facing the industry is the restriction of PFAS chemicals, a largest ever restriction of chemical group in the history. PFAS are widely used across different sectors as they have unique desiable properties. However, the accumulating scientific evidence regarding their persistence, tendency to bioaccumilate, and potential adverse effects on both human health and the environment has resulted in intensified regulatory oversight.

The restriction of these chemicals causes supply chain disruptions, increased production costs, and potential product shortages in the market which may impact patient lives.

This white paper summarizes the significance of PFAS in both the medical device and pharmaceutical sectors, examines the impact of upcoming restrictions on the healthcare industry, and outlines the challenges and opportunities ahead for manufacturer.